BUDA
Buda Juice, Inc. (AMEX)
Consumer Defensive — Beverages - Non-Alcoholic
Buda Juice, Inc. engages in producing and distributing juice, lemonades, limeades, and wellness shots in the United States. The company offers clean-label beverages; citrus juices; and cold-pressed juices made from fruits and vegetables. The company serves wholesale clients. The company was incorporated in 2013 and is headquartered in Dallas, Texas.
None
1 analysts
$8.50
$-0.28 (-3.19%)
Target:
$14.00
(64.7%)
Sign in to add BUDA to a watchlist or set price alerts.
Price History
52-Week Range
Fundamentals
| Market Cap | $111.28M |
| P/E Ratio (TTM) | 35.42 |
| Forward P/E | - |
| EPS (TTM) | $0.25 |
| Dividend Yield | - |
| Profit Margin | 23.70% |
| Revenue Growth | 17.70% |
| ROE | 25.75% |
| Debt/Equity | 3.56 |
| Recommendation | None |
| Analyst Target | $14.00 |
| Analysts | 1 |
| Indexes | AMEX |
Technical Indicators
| RSI (14) | 65.9 |
| Beta | - |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $12.00 |
| 52-Week Low | $6.25 |
| 50-Day Avg | $8.91 |
| 200-Day Avg | $9.19 |
| Avg Volume | 14.6K |
| Volume | 71.2K |
Performance Analysis
BULLISHBUDA shows predominantly bullish signals based on its fundamentals and technicals.
~
Trading at 39% of its 52-week range.
+
RSI at 65.9 shows positive momentum.
-
Price is below both the 50-day and 200-day moving averages — in a downtrend.
~
Modest revenue growth of 17.7% year-over-year.
+
Healthy profit margin of 23.7%.
~
Wall Street consensus is "none" from 1 analysts.
+
Average analyst target of $14.00 implies 64.7% upside.
Recent News
Loading news...
Last updated: Jul 02, 2026 13:01 UTC
Back to Screener Export Report